CompanyDrug

Henlius’s HANBEITAI Bevacizumab Biosimilar BLA Accepted by FDA for Multiple Solid Tumors

CompanyDrug

U‑Yin Pharma’s EHT102 Gene Therapy Scores IND Approval Under NMPA’s 30‑Day Review for DFNB9 Hearing Loss

Genhouse Bio Raises RMB 300 Million in Cross‑Over Round Led by Green Pine Capital
CompanyDeals

Genhouse Bio Raises RMB 300 Million in Cross‑Over Round Led by Green Pine Capital

Haichang Biotech's HC016 Receives FDA Orphan Drug Designation for Osteosarcoma
CompanyDrug

Haichang Biotech’s HC016 Receives FDA Orphan Drug Designation for Osteosarcoma

Iktos and Servier Forge EUR 1 Billion+ AI Drug Discovery Collaboration
CompanyDeals

Iktos and Servier Forge EUR 1 Billion+ AI Drug Discovery Collaboration

CompanyDrug

Sanofi’s Teizeild Wins EU Approval as First Disease‑Modifying Therapy for Type 1 Diabetes

CompanyDrug

CSPC’s Prusogliptin/Metformin FDC NDA Accepted by NMPA for Type 2 Diabetes, Targeting 60 M Underserved Patients

CompanyMedical Device

Lifetech’s CS Stent System Wins NMPA Fast‑Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk

CompanyDrug

ImmuneOnco’s Timdarpacept Receives NMPA Nod for Atherosclerosis Study, Expanding CD47 Platform

CompanyDrug

Hengrui’s SHR‑1826 ADC Earns Breakthrough Therapy Designation for c‑Met Overexpressed NSCLC

CompanyDrug

Hengrui’s HRS-7535 GLP-1R Agonist Cleared for Hypertension with Obesity Study in China

CompanyDrug

Merck and Abbisko’s Pimicotinib NDA Accepted by FDA for TGCT, Building on China Approval